General Information of Drug (ID: DM0O5HZ)

Drug Name
NaBen
Indication
Disease Entry ICD 11 Status REF
Schizophrenia 6A20 Phase 2/3 [1]
Cross-matching ID
TTD ID
D02SDY

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)